Hospitals: Apollo Hospitals Enterprise Ltd owns the largest revenue base; Narayana Hrudayalaya Ltd has the fastest current growth.
Nifty Hospitals Index — Constituents & Performance
The Hospitals companies below are the listed Indian Hospitals universe this page tracks — the same constituent set people search for as the Nifty Hospitals index. Every figure is equal-weighted across those companies, so one large constituent cannot set the reading. Each number carries its own as-of date.
The sector itself · before any single company
How has Hospitals moved against NIFTY 500?
The line below covers 5.1 years. Over the most recent two of them this sector is 50% ahead of NIFTY 500. Earnings across its companies grew 13% on average over the last four reported quarters. It has been ahead of NIFTY 500 on a rolling three-month view for 17 weeks running.
LEADER · ahead 17w✓Price and the fundamentals both up14 of 18 companies ahead of NIFTY 500 by 5% or more over three months1 is 20% or more behind over a year while earnings grew 20% or more
Hospitals, equal-weighted, based at 200NIFTY 500, same base, same starttrailing 12-month earnings per share risingfalling
Strength anatomyMixedHow much of the sector is participating, how recently, and whether the movers score well.
Together14 of 18 stocks moving
Fresh5 crossed in the last 4 weeks
Backed by scoresmovers score +1 vs the sector average
Down the cap ladder — bar is now, tick is four weeks ago
Large3/4+2
Mid6/6+2
Small5/8−2
Participation is not spreading downward this month; the larger companies are still carrying most of it.
Both lines start at 200 in the same week, so the distance between them is the whole story: the sector line is an equal-weighted index of its 18 companies. The bars underneath are trailing 12-month earnings per share, one bar per reported quarter, each member rebased to 100 at the start and the sector taking the median — so a price line pulling away from flat bars is a re-rating, not earnings. A bar turns red when that figure is lower than the quarter before. Rules are fixed and applied identically everywhere on this site: ahead by 5% or more over three months, or behind by 20% or more over a year while earnings grew 20% or more. Hover any point to read both values and the gap. This is a description of what the numbers did, not advice.
Sector relative strength · before individual stocks
Is Hospitals outperforming NIFTY 500?
The 52-week comparison of Hospitals against NIFTY 500 is not available from the current market series. 16 of 19 covered companies currently beat NIFTY on Mansfield relative strength, so leadership inside the sector is selective. Sakar Healthcare Ltd is the strongest against the sector itself at +58.1%. Readings are as of 2026-07-19.
—Sector vs NIFTY 500 · 13 weeks
—Sector vs NIFTY 500 · 52 weeks
16/19Stocks leading NIFTY 500
7/19Stocks leading sector
Sector metric: 17.6 as of 2026-07-19 · NARROWING · rising.
The central tension: the companies with the most scale are not necessarily the companies creating the most change.
Start with scale. Then earnings trajectory. Then business quality. Only after those three agree should price leadership carry much weight.
Bottom line
The 52-week sector comparison is unavailable. 16 of 19 covered companies currently have positive Mansfield relative strength versus NIFTY 500. Apollo Hospitals Enterprise Ltd leads with revenue of ₹25,229 crore, based on 19 of 19 comparable companies through Mar 2026. Narayana Hrudayalaya Ltd has the fastest current revenue growth at 44%, across 19 of 19 comparable companies.
Is the Hospitals sector outperforming NIFTY 500?
The 52-week sector comparison is unavailable. 16 of 19 covered companies currently have positive Mansfield relative strength versus NIFTY 500.
Which Hospitals company is largest by revenue?
Apollo Hospitals Enterprise Ltd leads with revenue of ₹25,229 crore, based on 19 of 19 comparable companies through Mar 2026.
Which Hospitals company is growing fastest?
Narayana Hrudayalaya Ltd has the fastest current revenue growth at 44%, across 19 of 19 comparable companies.
Which Hospitals company has the strongest 4-Factor Sector Score?
KMC Speciality Hospitals (India) Ltd ranks first at 80.2/100 with 79% evidence confidence. The score prioritizes research; it is not a buy recommendation.
Which Hospitals company reports the most CAPEX?
Global Health Ltd reports the largest latest CAPEX at ₹67 crore, with 5 of 19 companies comparable.
Which Hospitals company has the least gross debt?
Indraprastha Medical Corporation Ltd has the lowest comparable gross debt at ₹37 crore. Apollo Hospitals Enterprise Ltd has the highest at ₹8,493 crore.
Which Hospitals company has the lowest comparable PEG?
Indraprastha Medical Corporation Ltd has the lowest comparable Guarded PEG at 0.92, among 11 of 19 companies that pass the metric’s comparability rules.
How much history does this Hospitals comparison include?
The page compares up to 20 reported quarters per company for fundamentals, CAPEX, debt and valuation, ending Jun 2026. Missing observations remain blank rather than being estimated.
How is the 4-Factor Sector Score calculated?
The four visible contributions add directly: growth and earnings up to 35 points, capital efficiency up to 25, valuation up to 20, and relative strength up to 20. Missing or stale evidence moves only the affected contribution toward neutral.
Companies
19
complete canonical membership
Combined market value
₹5.5 L Cr
Apollo Hospitals Enterprise Ltd
Revenue growing
19/19
positive TTM year-on-year growth
Beating NIFTY 500
16/19
positive Mansfield relative strength
Global company selection
00 · research priority, made explicit
4-Factor Sector Score
An additive sector-relative research score. The four displayed point contributions always equal the total: Growth & earnings (35), Capital efficiency (25), Valuation (20), and Relative strength (20). Missing or stale evidence is absorbed inside the affected factor, never applied as a hidden adjustment.
KMC Speciality Hospitals (India) Ltd has the strongest current balance of earnings trajectory, business quality, valuation and price confirmation, with 79% evidence confidence.
Indraprastha Medical Corporation Ltd looks inexpensive relative to peers or its own history, but its earnings trajectory has not yet earned the valuation signal.
Rainbow Childrens Medicare Ltd has stronger price confirmation than earnings confirmation; that is a research prompt, not permission to chase.
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is guarded: positive earnings, positive 5–60% three-year EPS growth, and a positive P/E are required.
Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -7.9% and the one-year return is -10.3%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -8.4% and the one-year return is 19.3%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15.6/35Growth & earnings
Revenue 4.8% · PAT 100% · OPM change 2 pp
62% evidence
4.2/25Capital efficiency
ROCE 6.5% · debt/equity 0.59×
95% evidence
9.0/20Valuation
P/E 47.1× · PEG —
50% evidence
3.2/20Relative strength
RS sector -28.4% · RS bench -13.8% · 1Y -16.2%
70% evidence
01 · compare level, then change
Revenue Scale & Growth Durability
Apollo Hospitals Enterprise Ltd has the highest Revenue among the 19 Hospitals companies compared here, at ₹25,229 crore. Fortis Healthcare Ltd is next at ₹9,128 crore. Narayana Hrudayalaya Ltd has the highest Revenue growth at 44%, so level and change sit with different companies. 19 of 19 companies report a comparable reading, the latest through Mar 2026.
What the numbers say: Apollo Hospitals Enterprise Ltd is the scale leader at ₹25,229 crore, 176.4% ahead of Fortis Healthcare Ltd. Narayana Hrudayalaya Ltd's growth is 44% from a ₹7,896 crore base, with 19 reported observations in the 20-quarter window. Treat the growth leader as an acceleration candidate, not as equally proven scale.
Investor read: Apollo Hospitals Enterprise Ltd is the scale benchmark; Narayana Hrudayalaya Ltd is the acceleration watch. Promote the challenger only if growth persists and converts into margin and returns.
This conclusion weakens if: Apollo Hospitals Enterprise Ltd's growth falls below Narayana Hrudayalaya Ltd's for two consecutive comparable reports while operating margin also compresses.
Revenue is compared on a common reported-currency basis. Growth is year-on-year, so seasonality does not masquerade as progress.
3Yatharth Hospital & Trauma Care Services Ltd YATHARTH36%
4KMC Speciality Hospitals (India) Ltd 52452033%
5Krishna Institute of Medical Sciences Ltd KIMS29%
Revenue · company comparison
19/19 level · 19/19 change
Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.
All-company data · latest reported quarter
Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
KMC Speciality Hospitals (India) Ltd has the highest OPM among the 19 Hospitals companies compared here, at 31%. The same company also holds the highest Margin change, at +6 percentage points. 19 of 19 companies report a comparable reading, the latest through Mar 2026. Its OPM series carries 19 reported observations across the 20-quarter window.
What the numbers say: KMC Speciality Hospitals (India) Ltd leads both opm at 31% and margin change at +6 percentage points.
LeaderKMC Speciality Hospitals (India) Ltd · 31%
Gap0% versus #2 · Rainbow Childrens Medicare Ltd
Persistence4/8 recent comparable periods
Coverage19/19 companies · 355 observations
Investor read: KMC Speciality Hospitals (India) Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current margin change signal.
Operating margin compares operating profit with revenue. Improvement is measured in percentage points, not percentage growth.
Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.
All-company data · latest reported quarter
Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Apollo Hospitals Enterprise Ltd has the highest Net profit among the 19 Hospitals companies compared here, at ₹2,002 crore. Max Healthcare Institute Ltd is next at ₹1,442 crore. KMC Speciality Hospitals (India) Ltd has the highest Profit growth at the 100% top of the scoring scale, so level and change sit with different companies.
What the numbers say: Apollo Hospitals Enterprise Ltd leads with ₹2,002 crore of TTM profit, 38.8% above Max Healthcare Institute Ltd. KMC Speciality Hospitals (India) Ltd shows ≥100% on the scoring scale (108.7% uncapped) growth from a ₹48 crore profit base. Compare the size of the base and persistence before ranking acceleration above profit scale.
Investor read: Apollo Hospitals Enterprise Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current profit growth signal.
Net profit is the residual after operating costs, interest and tax. Growth off a loss or near-zero base is excluded from the fastest-grower rank.
Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.
All-company data · latest reported quarter
Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Global Health Ltd has the highest CAPEX among the 19 Hospitals companies compared here, at ₹67 crore. Jupiter Life Line Hospitals Ltd is next at ₹27 crore. Rainbow Childrens Medicare Ltd has the highest CAPEX intensity at 11.8%, so level and change sit with different companies. 5 of 19 companies report a comparable reading, the latest through Mar 2026.
What the numbers say: Global Health Ltd reports ₹67 crore of CAPEX; Rainbow Childrens Medicare Ltd has the highest covered intensity at 11.8%. Coverage is only 5 of 19 companies and 12 reported observations, so this is partial evidence—not a complete sector rank.
LeaderGlobal Health Ltd · ₹67 crore
Gap148.1% versus #2 · Jupiter Life Line Hospitals Ltd
Persistence2/2 recent comparable periods
Coverage5/19 companies · 12 observations
Investor read: Use the CAPEX rank as a diligence queue. Verify commissioning, utilization, cash conversion and post-investment ROCE before treating spend as value creation.
This conclusion weakens if: CAPEX rises without higher utilization, operating cash flow or incremental returns.
CAPEX is cash spent on property, plant, equipment and other reported capital assets. CAPEX intensity divides that spend by revenue; high intensity is a reinvestment signal, not proof that the reinvestment will earn attractive returns.
CAPEXlargest spenders
1Global Health Ltd MEDANTA₹67 Cr
2Jupiter Life Line Hospitals Ltd JLHL₹27 Cr
3Rainbow Childrens Medicare Ltd RAINBOW₹25 Cr
4GPT Healthcare Ltd GPTHEALTH⚠ unverified₹6 Cr
5Yatharth Hospital & Trauma Care Services Ltd YATHARTH₹3 Cr
CAPEX intensityhighest reinvestment intensity
1Rainbow Childrens Medicare Ltd RAINBOW12%
2Jupiter Life Line Hospitals Ltd JLHL11%
3Global Health Ltd MEDANTA9.9%
4GPT Healthcare Ltd GPTHEALTH⚠ unverified5.6%
5Yatharth Hospital & Trauma Care Services Ltd YATHARTH3.2%
Capital expenditure · company comparison
5/19 level · 5/19 change
Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.
Withheld from this chart: Apollo Hospitals Enterprise Ltd (APOLLOHOSP) — its two data sources disagree by up to 6.3% on reported income across 14 comparable periods, so its derived ratios are withheld; Fortis Healthcare Ltd (FORTIS) — its two data sources disagree by up to 12% on reported income across 14 comparable periods, so its derived ratios are withheld; Krishna Institute of Medical Sciences Ltd (KIMS) — its two data sources disagree by up to 27% on reported income across 14 comparable periods, so its derived ratios are withheld; Healthcare Global Enterprises Ltd (HCG) — its two data sources disagree by up to 95% on reported income across 14 comparable periods, so its derived ratios are withheld. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
All-company data · latest reported quarter
Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
Capacity base is net fixed assets plus capital work in progress, straight off the reported balance sheet. It is not cash spent, so it answers a narrower question than CAPEX — but it is reported for companies whose cash-flow CAPEX is not published, which is why it leads here. Missing years remain blank; annual values are never relabelled as quarters.
Full annual capacity base, operating cash flow, CAPEX and free cash flow history
Capacity base · net fixed assets + CWIP · fiscal-year history
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Indraprastha Medical Corporation Ltd has the lowest Gross debt among the 19 Hospitals companies compared here, at ₹37 crore. Sakar Healthcare Ltd is next at ₹55 crore. The same company also holds the lowest Net debt, at ₹226 crore net cash. 19 of 19 companies report a comparable reading, the latest through Mar 2026.
What the numbers say: Indraprastha Medical Corporation Ltd has the clearest covered balance-sheet capacity with ₹226 crore net cash and gross debt of ₹37 crore. Absolute debt alone does not identify the strongest balance sheet because company scale differs; net debt and debt-to-equity carry more information.
LeaderIndraprastha Medical Corporation Ltd · ₹37 crore
Gap32.7% versus #2 · Sakar Healthcare Ltd
Persistence8/8 recent comparable periods
Coverage19/19 companies · 278 observations
Investor read: Prioritize net-cash capacity and leverage relative to operating scale, not the smallest absolute rupee debt.
This conclusion weakens if: Net debt rises faster than revenue and profit for two consecutive reported periods.
Gross debt shows contractual borrowings. Net debt subtracts reported cash; a negative value means net cash. Lower debt can create capacity, but should be read against the scale and capital intensity of the business.
Gross debtlowest gross debt
1Indraprastha Medical Corporation Ltd INDRAMEDCO₹37 Cr
1Indraprastha Medical Corporation Ltd INDRAMEDCO₹-226 Cr
2Yatharth Hospital & Trauma Care Services Ltd YATHARTH₹1 Cr
3GPT Healthcare Ltd GPTHEALTH⚠ unverified₹44 Cr
4Jupiter Life Line Hospitals Ltd JLHL₹44 Cr
5Kovai Medical Center & Hospital Ltd KOVAI₹56 Cr
Debt and balance-sheet capacity · company comparison
19/19 level · 14/19 change
Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.
All-company data · latest reported quarter
Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Showing the 12 largest of 14 companies with a series here. The remaining 2 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Indraprastha Medical Corporation Ltd has the highest ROCE among the 19 Hospitals companies compared here, at 35.8%. KMC Speciality Hospitals (India) Ltd is next at 26%. KMC Speciality Hospitals (India) Ltd has the highest ROCE change at +9 percentage points, so level and change sit with different companies. Its ROCE series carries 15 reported observations across the 20-quarter window.
What the numbers say: Indraprastha Medical Corporation Ltd leads ROCE at 35.8%, 9.8 percentage points above KMC Speciality Hospitals (India) Ltd. KMC Speciality Hospitals (India) Ltd has the strongest latest improvement at +9 percentage points. Read the leader beside the density of its reported history: a sparse high return is a candidate; a repeated high return is evidence of durability.
LeaderIndraprastha Medical Corporation Ltd · 35.8%
Gap37.7% versus #2 · KMC Speciality Hospitals (India) Ltd
Persistence4/8 recent comparable periods
Coverage19/19 companies · 204 observations
Investor read: Indraprastha Medical Corporation Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current roce change signal.
ROCE asks how much operating return the business earns on the capital employed. Direction matters, but a single exceptional year should not be mistaken for durability.
ROCEhighest
1Indraprastha Medical Corporation Ltd INDRAMEDCO36%
Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.
Withheld from this chart: Apollo Hospitals Enterprise Ltd (APOLLOHOSP) — its two data sources disagree by up to 6.3% on reported income across 14 comparable periods, so its derived ratios are withheld; Fortis Healthcare Ltd (FORTIS) — its two data sources disagree by up to 12% on reported income across 14 comparable periods, so its derived ratios are withheld; Krishna Institute of Medical Sciences Ltd (KIMS) — its two data sources disagree by up to 27% on reported income across 14 comparable periods, so its derived ratios are withheld; Healthcare Global Enterprises Ltd (HCG) — its two data sources disagree by up to 95% on reported income across 14 comparable periods, so its derived ratios are withheld. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
All-company data · latest reported quarter
Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
Showing the 12 largest of 14 companies with a series here. The remaining 2 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Showing the 12 largest of 14 companies with a series here. The remaining 2 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Indraprastha Medical Corporation Ltd has the lowest Guarded PEG among the 19 Hospitals companies compared here, at 0.92×. Artemis Medicare Services Ltd is next at 1.09×. The same company also holds the lowest P/E, at 18.2×. 11 of 19 companies report a comparable reading, the latest through Mar 2026.
What the numbers say: Indraprastha Medical Corporation Ltd has the lowest comparable Guarded PEG at 0.92×, 15.6% below Artemis Medicare Services Ltd. Only 11 of 19 companies pass the guard, so no broad “cheapest stock” conclusion is defensible unless the current multiple, own-history position and growth durability agree.
LeaderIndraprastha Medical Corporation Ltd · 0.92×
Gap15.6% versus #2 · Artemis Medicare Services Ltd
Persistence0/8 recent comparable periods
Coverage11/19 companies · 109 observations
Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.
This conclusion weakens if: The next two comparable reports reverse the current p/e signal.
PEG is shown only when earnings are positive and three-year EPS growth is between 5% and 60%. It is recomputed consistently as the trailing P/E divided by that growth rate — reported earnings, never an expected-earnings multiple. On Indian companies it is shown only where the two data sources reconciled. A missing PEG is more honest than a low-base fiction.
Guarded PEGlowest PEG
1Indraprastha Medical Corporation Ltd INDRAMEDCO0.9
2Artemis Medicare Services Ltd ARTEMISMED1.1
3Global Health Ltd MEDANTA1.1
4Kovai Medical Center & Hospital Ltd KOVAI1.5
5Dr Agarwals Eye Hospital Ltd DRAGARWQ1.7
P/Elowest P/E
1Indraprastha Medical Corporation Ltd INDRAMEDCO18.2
2Kovai Medical Center & Hospital Ltd KOVAI26.2
3GPT Healthcare Ltd GPTHEALTH⚠ unverified30.4
4Dr Agarwals Eye Hospital Ltd DRAGARWQ34.6
5Artemis Medicare Services Ltd ARTEMISMED41.2
Valuation · company comparison
11/19 level · 19/19 change
Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.
All-company data · latest reported quarter
Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Indraprastha Medical Corporation Ltd has the lowest EV/EBITDA among the 19 Hospitals companies compared here, at 10.6×. GPT Healthcare Ltd is next at 12×. Shalby Ltd has the lowest P/BV at 1.75×, so level and change sit with different companies. 19 of 19 companies report a comparable reading, the latest through Mar 2026.
What the numbers say: Indraprastha Medical Corporation Ltd leads ev/ebitda at 10.6×; Shalby Ltd leads p/bv at 1.75×.
LeaderIndraprastha Medical Corporation Ltd · 10.6×
Gap11.7% versus #2 · GPT Healthcare Ltd
Persistence0/8 recent comparable periods
Coverage19/19 companies · 328 observations
Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.
This conclusion weakens if: The next two comparable reports reverse the current p/bv signal.
EV/EBITDA includes debt in enterprise value and is useful across different capital structures. P/BV prices the company against its own book. Both are market multiples on reported figures, not intrinsic-value estimates and not forecasts.
EV/EBITDAlowest EV/EBITDA
1Indraprastha Medical Corporation Ltd INDRAMEDCO10.6
2GPT Healthcare Ltd GPTHEALTH⚠ unverified12.0
3Shalby Ltd SHALBY⚠ unverified12.2
4Kovai Medical Center & Hospital Ltd KOVAI12.5
5Artemis Medicare Services Ltd ARTEMISMED16.2
P/BVlowest P/BV
1Shalby Ltd SHALBY⚠ unverified1.8
2Indraprastha Medical Corporation Ltd INDRAMEDCO4.5
3Yatharth Hospital & Trauma Care Services Ltd YATHARTH4.5
4Artemis Medicare Services Ltd ARTEMISMED4.7
5Kovai Medical Center & Hospital Ltd KOVAI4.9
Enterprise and book valuation · company comparison
19/19 level · 19/19 change
Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.
All-company data · latest reported quarter
Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Sakar Healthcare Ltd has the strongest one-year price move in Hospitals at +148.4%. It also leads on Mansfield relative strength against NIFTY at +74.3%. 16 of 19 covered companies are above zero on that measure. Every line covers 313 weekly closes through 2026-07-17.
Every price line is indexed to 100 over the chosen window. Mansfield relative strength compares a price ratio with its own 52-week average; zero separates leadership from lagging.
Price and relative strength
Price is rebased to 100 inside the selected window. Pair ratio rebases each selected company against one chosen denominator.
Before the conclusion · check the blind spots
What can make this comparison misleading?
This Hospitals comparison names 6 specific ways its own evidence can mislead, all listed below. All 19 companies here report on comparable dates, so no rank carries a stale marker. 3 draw at least one figure from a second feed with too little overlap to cross-check. 4 have second-feed figures withheld because the two sources disagree.
Keep these limits visible
A high growth rate can be a low-base artefact. The page keeps level and change separate for that reason.
A high ROCE can be temporary or flattered by a small capital base. Read it beside margin, cash conversion and reinvestment.
The 4-Factor Sector Score ranks research priority, not portfolio action. Management quality, catalysts and risks need equally fresh evidence before capital is deployed.
An “all companies” line chart preserves completeness, but rank changes should be checked against reporting dates before drawing a conclusion.
3 companies draw at least one figure from a second data feed with too little overlapping history to cross-check against the primary source; they are marked unverified wherever those figures appear.
4 companies are missing from the second-feed metrics by decision, not by absence: the two sources disagree, so nothing from the second is drawn. Read those rows as narrower evidence, never as a weaker business.
10 · the complete set
Which companies are included?
All 19 companies in the canonical Hospitals membership are listed below, largest market value first — nothing is silently dropped, even where a company reports too little to rank. The charts above default to a selective view; this register is the complete set, with each company's own latest reporting date beside it.
AHEAD means the company is beating the index by 5% or more over three months. LAGGING, FUNDAMENTALS UP means it is 20% or more behind over a year while its trailing twelve-month earnings grew 20% or more. Both rules are fixed and applied the same way in every sector.
How each company's sources stand: 3 of 19 companies draw at least one figure from a second data feed that could not be cross-checked against the primary source, because the two do not share enough reported history to compare. Those figures are marked unverified wherever they appear. 4 of 19 companies have a second data feed that is known to disagree with the primary source, so nothing from it is drawn: Apollo Hospitals Enterprise Ltd (APOLLOHOSP) — its two data sources disagree by up to 6.3% on reported income across 14 comparable periods, so its derived ratios are withheld; Fortis Healthcare Ltd (FORTIS) — its two data sources disagree by up to 12% on reported income across 14 comparable periods, so its derived ratios are withheld; Krishna Institute of Medical Sciences Ltd (KIMS) — its two data sources disagree by up to 27% on reported income across 14 comparable periods, so its derived ratios are withheld; Healthcare Global Enterprises Ltd (HCG) — its two data sources disagree by up to 95% on reported income across 14 comparable periods, so its derived ratios are withheld.
Evidence and freshness
How was this comparison built?
This comparison is built from the reported filings of 19 Hospitals companies, normalized to a common ₹ scale and a shared quarter axis of up to 20 quarters each. Fundamentals run through Jun 2026 and market data through 2026-07-24. A second data feed fills gaps only after identity and scale reconciliation, and missing observations are never interpolated.
FundamentalsThrough Jun 2026 · up to 20 quarters per company
Market dataThrough 2026-07-24 · weekly price and relative-strength history
Derived metricsGrowth, changes, CAPEX intensity, net debt, guarded PEG and P/BV÷ROE are calculated only when their inputs are comparable.
Score confidenceMissing and stale evidence reduces confidence and pulls the 0–100 research-priority score toward neutral.
A second feed is read only after its reported income is matched against the primary source on at least three overlapping periods. Where the two agree the figures fill silently. Where there is too little shared history to compare, the figures are still drawn — they are the only evidence there is — and marked ⚠ unverified everywhere they appear. Where the two are known to disagree, nothing from the second feed is drawn and the affected company is named under the chart it is missing from. Every company's standing is listed in the register above.
These 18 answers restate the Hospitals comparison above in question form. Every one is computed from the same 19 companies and the same reported filings as the rankings and charts, current through Jun 2026. Price and relative-strength answers run through 2026-07-24. Nothing here is estimated, and none of it is a recommendation.
What is the Nifty Hospitals index?
The Nifty Hospitals index tracks India's listed Hospitals companies as a single basket. This page follows the same 19 companies and equal-weights them, so every company's weekly return counts once whatever it is worth, and the reading belongs to the Hospitals sector rather than to its largest constituent. Figures are as of Jun 2026.
Which are the best Hospitals stocks in India?
Ranked by this page's four-factor score, KMC Speciality Hospitals (India) Ltd places first among 19 listed Hospitals companies, followed by Sakar Healthcare Ltd. That is a ranking of published data — earnings, quality, valuation and market behaviour as of Jun 2026 — and not a recommendation; Sector Alpha is not registered with SEBI as an investment adviser.
How many Hospitals stocks are listed in India?
This comparison covers 19 listed Hospitals companies in India, each above the size floor the site applies, with 20 quarters of reported figures per company where the filings exist. The full ranked list is on this page, as of Jun 2026.
Which Hospitals company is the biggest?
Apollo Hospitals Enterprise Ltd is the largest, with trailing-twelve-month revenue of ₹25,229 crore, ahead of Fortis Healthcare Ltd at ₹9,128 crore. That covers 19 of 19 companies with comparable reporting through Mar 2026.
Which Hospitals company is growing fastest?
Narayana Hrudayalaya Ltd has the fastest revenue growth at 44% year on year, across 19 of 19 comparable companies. Fast growth off a small base is not the same as proven scale — check whether the rate holds across several quarters on the chart above before treating it as a trend.
Which Hospitals company has the best profit margins?
KMC Speciality Hospitals (India) Ltd has the highest operating margin at 31%, from 19 of 19 comparable companies. KMC Speciality Hospitals (India) Ltd shows the biggest recent improvement, at +6 percentage points. A high margin matters most when it is holding or rising, not when it is peaking.
Which Hospitals company makes the most profit?
Apollo Hospitals Enterprise Ltd earns the most, at ₹2,002 crore of trailing-twelve-month net profit, from 19 of 19 comparable companies. KMC Speciality Hospitals (India) Ltd has the fastest profit growth at 100%, though growth off a small or recovering profit base overstates how much has actually changed.
Which Hospitals company earns the highest return on capital?
Indraprastha Medical Corporation Ltd leads on return on capital employed at 35.8%, across 19 of 19 companies. Read it beside the length of its reported history: a high return that repeats for years is evidence of a durable business, while a single high reading can be a small capital base or one good year.
Which Hospitals stock is the cheapest?
On guarded PEG — where a LOWER number is cheaper — Indraprastha Medical Corporation Ltd screens cheapest at 0.92×. Only 11 of 19 companies pass the comparability guard, so this is not a sector-wide "cheapest stock" verdict. Cheap on a multiple is a reason to investigate, never a reason to buy on its own.
Which Hospitals company has the strongest balance sheet?
Indraprastha Medical Corporation Ltd carries the lowest comparable gross debt at ₹37 crore, from 19 of 19 companies. Absolute rupee debt alone does not settle it, because company scale differs — net debt and debt-to-equity in the chart above carry more information, and a very low-debt balance sheet can also mean under-investment.
Which Hospitals stock has the strongest price momentum?
Sakar Healthcare Ltd has the strongest relative strength against NIFTY 500. Relative strength answers last, after growth, quality and valuation: price can move well before the fundamentals confirm it, and sometimes without them confirming at all.
Which Hospitals company scores highest for research priority?
KMC Speciality Hospitals (India) Ltd scores 80.2 out of 100 with 79% evidence confidence, from 30.8 points on growth and earnings, 18.9 on capital efficiency, 11 on valuation and 19.5 on relative strength. This ranks what deserves work next. It is not a buy recommendation, and management quality, catalysts and risk still need separate research.
How many Hospitals companies does this comparison cover, and over what period?
It compares 19 listed companies over up to 20 reported quarters of fundamentals and 10 fiscal years of capital allocation, ending Jun 2026, plus weekly price and relative-strength history. Membership is the full sector list — nothing is dropped for having thin data.
What is the total market cap of the Hospitals sector?
The 19 Hospitals companies on this page carry ₹5,49,244 crore of combined market value. Apollo Hospitals Enterprise Ltd is the largest at ₹1,26,610 crore, about 23% of the sector's total on its own. Market value moves with price, so this reading is dated 2026-07-29.
What is the Hospitals sector's P/E ratio?
The median price-to-earnings ratio across the 19 Hospitals companies on this page is 49.5×, measured on the 19 that report a comparable figure. A sector-level history for this multiple is not held here, so this is a cross-section of today, not a comparison with the sector’s own past. Figures are as of 2026-07-29.
How is the Hospitals sector performing?
16 of the 19 covered Hospitals companies are beating NIFTY 500 on Mansfield relative strength. A 52-week sector-versus-index comparison is not available from the current market series for this sector, so it is not quoted. Readings are as of 2026-07-29.
Why are some values on this page blank?
A blank means that company did not report a comparable figure for that period, so nothing is shown. Missing observations are never interpolated, carried forward, or replaced with a similar-looking accounting line, and a company with missing evidence has its research score pulled toward neutral rather than being scored as bad.
Is this investment advice?
No. Every figure here is a deterministic calculation from reported company filings and market data, published for research. It contains no recommendation to buy or sell any security, does not account for your circumstances, and is not a substitute for advice from a licensed adviser.